Replies to post #484208 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

They [NWBO management] continue to avoid questions on marketing application timelines, commercial manufacturing ability timelines, etc. They and their pals then get angry anyone should dare raise questions about their plans. They provide topline but after years of saying it would be imminently backed up with a journal, get mad at investors for wondering when the journal is coming out. It just seems like anger at investors is their posture. They didn’t change clinicaltrials.gov endpoints until after topline, even though Dr. Ashkan seems to confirm it was approved by all four regulators beforehand. Les’s old saw about catching shorts off guard has proven quite the opposite. They did not surprise anyone with their NYAS or ASCO delivery, and left out timelines to boot. Again helping bears. The science appears good, and partial results appear good, but they leave a gap on follow up journal timing that might otherwise confirm matters.

No one could have stated this better.

The argument that they had vague purposes which we are not given to know just does not stand up by comparison.

The ASM would be the best time (besides yesterday, so to speak) for NWBO to address these issues but of course, they won't and it seems they are delaying even the need to duck and dodge at the ASM for as long as possible.

[wimike]

TY Flipper for being so honest. Too bad they do not hold cc with a Q&A period at the end. It would be nice if you could ask them a couple of questons if they would actually answer them.

This so-called "quiet period" to me, which has been going on way too long is just an excuse. I sure hope we get $5/share when we show a plan and have a path to FDA approval, and not in 3 years added on to this almost 2 years after data lock.

I guess I will stick to the stock I have which is enough, I am not a greedy person. I will be grateful for $5 and finally retire in my 70s. Yes, I still work but part-time these days for a great company chess.com. Never thought I would get a job I enjoy doing. Too bad I wasn't 30 years younger in this online age.

Thanks, again!

[FeMike]

They and their pals then get angry anyone should dare raise questions about their plans.

This is the part that gets me. They get angry with investors as if it's wrong to be even slightly perturbed by the fact that the company hasn't released a statement on the progress of the trial in 18 months.